Salehian, B., Wang, C., Alexander, G., Davidson, T., et al. (1995) Pharmacokinetics, Bioefficacy, and Safety of Sublingual Testosterone Cyclodextrin in Hypogonadal Men: Comparison to Testosterone Enanthate—A Clinical Research Center Study. Journal of Clinical Endocrinology and Metabolism, 80, 3567-3575.

has been cited by the following article:

• TITLE: Cardiovascular Benefits of Testosterone Replacement Therapy in the Andropausal Male

  AUTHORS: Satya K. Vatti, Raef Madanieh, Abed Madanieh, Constantine E. Kosmas, Timothy J. Vittorio

  KEYWORDS: Cardiovascular, Hormones, Hypogonadism, Testosterone, Therapy

  JOURNAL NAME: Health, Vol.7 No.9, September 25, 2015

  ABSTRACT: Androgen deficiency has been receiving a lot of attention as an evolving health concern in the in-dustrialized world. With population aging, hypogonadism has become a challenging medical problem confronting practicing physicians. The importance of this increasingly prevalent disease arises from its potentially debilitating and serious consequences, such as atherosclerosis, diabetes mellitus, metabolic disorders, muscular weakness, psychiatric illness, sexual dysfunction and vascular inflammation. When left untreated, testosterone deficiency is associated with increased cardiovascular mortality.